What are Mission Vision & Core Values of UCB Company?

UCB Bundle

Get Full Bundle:

	PESTLE	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What drives UCB's biopharmaceutical innovation?

Mission and vision statements are crucial for any successful enterprise, defining its purpose and guiding principles. They serve as strategic blueprints for business decisions, fostering corporate culture and identity. UCB S.A. is a global biopharmaceutical company with a strong presence in immunology and neurology.

Their dedication to developing innovative medicines for severe diseases highlights their industry impact. UCB's mission, vision, and core values guide their research, patient strategies, and corporate behavior to improve lives. For a broader understanding, consider the UCB PESTEL Analysis.

The UCB company mission focuses on elevating the lives of patients and their families through innovative medicines, creating positive change across society. They continuously advance science and embrace new knowledge, leveraging scientific progress in genetics, biomarkers, and human biology. This commitment ensures they address unmet medical needs globally.

Patient-Centric Focus

UCB's purpose statement emphasizes creating value for patients, particularly those with severe neurological and immunological diseases.

Innovative Solutions

The company provides innovative medicines and solutions designed to improve the quality of life for patients and their families.

Global Market Scope

UCB operates on a global scale, addressing unmet medical needs across various regions.

Scientific Advancement

A core aspect of the UCB mission is continuous advancement in science, leveraging new knowledge and skills.

Patient Experience Integration

UCB incorporates individual patient and caregiver experiences into their medicine discovery and development processes.

Significant R&D Investment

Nearly 30% of UCB's overall revenue is invested in scientific innovation, reflecting their commitment to differentiated solutions.

UCB's purpose is to create value for patients now and in the future. They fulfill this purpose by elevating the lives of patients and their families through their medicines, creating positive change across society. UCB is continuously working to advance science and embrace new knowledge, leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology. The mission statement clearly identifies target customers as patients and their families living with severe neurological and immunological diseases. The products and services offered are innovative medicines and solutions designed to improve quality of life. The market scope is global, with a focus on addressing unmet medical needs. A unique value proposition lies in their patient-centric approach, incorporating individual experiences of patients and caregivers into the discovery, development, and delivery of medicines. For example, UCB's investment in scientific innovation, which is nearly 30% of their overall revenue, directly reflects their mission to advance science and create differentiated solutions for patients. Additionally, their patient support programs like UCBCares® demonstrate their commitment to elevating lives beyond just providing medication, offering personalized support throughout the patient's treatment journey. This mission is strongly customer-centric and innovation-focused, emphasizing tangible improvements in patient outcomes. For more details on their market approach, see the Target Market of UCB article. This aligns with the UCB company mission to improve patient lives and highlights UCB core values in practice for patients.

UCB SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

UCB's vision is to become a global leader in biotechnology, transforming the lives of individuals with severe neurological and immunological conditions. This patient-centric approach drives their scientific innovation, aiming to deliver meaningful solutions. The company projects 2025 revenue between €6.5 billion and €6.7 billion, demonstrating strong financial health to support this ambition.

Patient-Centric Focus

The UCB mission to improve patient lives is central, ensuring all efforts are geared towards addressing unmet medical needs.

Global Leadership

UCB's vision for the future of healthcare includes becoming a leading biotechnology company worldwide.

Scientific Innovation

Driven by science, UCB's strategic goals include significant investment in R&D, with over €1 billion planned for pipeline advancements.

Sustainability Commitment

UCB core values include corporate social responsibility, aiming for a 50% reduction in greenhouse gas emissions by 2025.

Robust Pipeline

The company expects news flow from nine innovative potential medicines in 2025, reinforcing UCB's vision for innovation in medicine.

Financial Strength

With 2024 revenue at €6.15 billion, a 17% year-over-year increase, UCB demonstrates strong financial backing for its mission.

UCB's ambition is to transform the lives of people living with severe diseases, with a specific focus on neurology and immunology disorders. This UCB company vision places patients at the core of their operations, emphasizing that they are 'Inspired by Patients. Driven by Science.' This future-oriented vision aims to 'transform' lives rather than just treat symptoms, reflecting a global scope to become a leader in biotechnology. UCB plans to invest over €1 billion in Research & Development (R&D) over the next few years to advance pipeline projects targeting unmet medical needs. The UCB purpose statement also incorporates a strong commitment to sustainability, aiming for a 50% reduction in greenhouse gas emissions by 2025 compared to 2019 levels. Based on the company's current trajectory, with 2024 revenue reaching €6.15 billion, a 17% year-over-year increase, and a 2025 revenue forecast of €6.5-€6.7 billion, the UCB company mission and vision appear both aspirational and realistic. Their robust pipeline, with nine innovative potential medicines expected to provide news flow in 2025, further supports their ambition for industry leadership and patient impact. For more insights into the company's structure, refer to the article on Owners & Shareholders of UCB.

UCB PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The UCB core values are fundamental to its identity, shaping its operational strategies and fostering a culture of innovation and patient-centricity. These principles guide the company's decisions, ensuring alignment with its overarching mission and vision.

UCB is guided by seven core values that drive its business conduct: Innovation, Passion for performance, Entrepreneurship, Integrity, Care, Accountability, and Embracing difference. These values collectively define the UCB company culture and its approach to healthcare.

Innovation

Innovation is the bedrock of UCB's operations, reflecting the reliance of patients on the company to develop new medicines that significantly improve their quality of life. This value manifests in product development through substantial R&D investments, which were approximately 20% of revenue in 2023, amounting to €1.2 billion, leading to the clinical development of five new drug candidates.

Passion for Performance

This value signifies UCB's dedication to continuous improvement to deliver the best for patients. It manifests in business practices through rigorous clinical trials and striving for optimal outcomes for their therapies. For example, UCB's 2024 financial performance, with a 17% year-over-year revenue increase to €6.15 billion, demonstrates their drive for strong results that enable further investment in patient solutions.

Entrepreneurship

UCB embraces an entrepreneurial spirit by constantly striving to innovate its products, improve patient services, and create sustainable value for investors. This is evident in their strategic investments, such as the significant planned investment in a new state-of-the-art biologics manufacturing facility in the US, which is projected to have an economic impact of approximately $5 billion and create around 300 permanent jobs.

Integrity

Acting with integrity and ensuring flawless quality in all endeavors is paramount for UCB. This is reflected in their ethical business practices, upholding applicable laws and regulatory requirements, and maintaining transparency through quarterly financial disclosures. It builds trust with patients, healthcare professionals, and partners, reinforcing the UCB purpose statement.

Care

UCB demonstrates care for patients, customers, and people. This is deeply embedded in their customer relations, as seen in their patient-centric approach and support services like UCBCares®, which provides personalized assistance to patients prescribed UCB products. In corporate culture, it translates to caring for and valuing employees, aiming to provide an optimal individual experience.

Accountability

Accountability is integral to UCB's operations, pushing the company to take ownership of its results and impacts, both financially and socially. UCB reported an employee accountability score of 92% based on a recent internal survey. This value is also demonstrated through their commitment to sustainability goals, including a 30% reduction in carbon footprint by 2030.

Embracing Difference

UCB recognizes diversity as a cornerstone of its success, encouraging and respecting different talents and perspectives to strengthen the organization. This manifests in their inclusive workplace culture, where everyone is empowered to contribute their unique perspectives, fostering collaboration and innovation, aligning with UCB core values in leadership.

These UCB core values collectively differentiate the company, fostering a culture deeply rooted in patient-centricity, scientific excellence, ethical conduct, and a commitment to sustainable impact. To understand how these values influence the company's strategic decisions, explore the next chapter on the UCB mission vision values and their impact on strategic goals. For further insights into the competitive landscape, consider reading about the Competitors Landscape of UCB.

UCB Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

A company's mission and vision are foundational, shaping its strategic direction and decision-making processes. These statements articulate the organization's purpose and its aspirations for the future, guiding every initiative.

UCB's Mission and Vision: Patient-Centricity in Action

UCB's core purpose, to 'create value for patients now and in the future,' directly influences its strategic focus on severe diseases within neurology and immunology.

• The company reinvests nearly 30% of its revenue into Research & Development to foster innovation and address unmet patient needs.
• This R&D focus has led to successful product launches, such as BIMZELX, which achieved global sales of €607 million in 2024.
• RYSTIGGO, another key product, generated €202 million in sales in the same year, showcasing the tangible impact of their strategy.
• UCB's vision to 'transform the lives of people living with severe diseases' drives market expansion and strategic partnerships.
• The company reached over 3.1 million patients in 2024, underscoring its commitment to accessibility.

Strategic Alignment with Patient Needs

UCB's mission and vision are not mere statements but active drivers of its strategic goals, ensuring that all efforts are directed towards improving patient lives.

R&D Investment as a Strategic Pillar

A significant portion of UCB's revenue is dedicated to R&D, a clear indicator of how its mission translates into tangible investment in scientific advancement.

Market Expansion Driven by Vision

The company's vision to reach more patients globally influences decisions regarding manufacturing capacity and supply chain reinforcement, as seen with its US facility investment.

Economic Impact and Global Reach

Investments in infrastructure, like the new US biologics facility, are projected to have a substantial economic impact, estimated at approximately $5 billion, while also enhancing global product accessibility.

Leadership's Commitment

The CEO's statements highlight how manufacturing expansion directly supports the ambition to bring pipeline products to patients worldwide, reinforcing the mission's influence.

UCB's Growth Strategy

Understanding the Growth Strategy of UCB provides further insight into how its mission and vision are operationalized.

UCB's mission and vision are pivotal in guiding its strategic decisions, from R&D investments to global expansion, ensuring a consistent focus on patient value. Explore core improvements to UCB's mission and vision in the next chapter.

UCB Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

UCB's mission and vision are foundational to its operations, guiding its strategic direction and commitment to patients. Enhancements could focus on integrating long-term quantitative goals and explicitly acknowledging emerging healthcare trends.

Incorporate Long-Term Aspirational Targets

While UCB has set a 2025 target for greenhouse gas emission reduction, extending its vision to include broader, longer-term environmental or societal impact goals would further solidify its commitment to sustainability as a core business driver.

Emphasize Health Equity in Vision Statement

Explicitly integrating the concept of 'health equity' into the vision statement would better align with current market demands and UCB's stated sustainability commitments, reinforcing its dedication to equitable healthcare access.

Acknowledge Digital Health and AI in Mission

Refining the mission statement to subtly acknowledge the role of digital health and artificial intelligence, such as a commitment to 'leveraging cutting-edge digital technologies to personalize treatment,' would better reflect the evolving healthcare landscape.

Frame Refinements as Growth Opportunities

Presenting these potential refinements as growth opportunities allows UCB to adapt its guiding principles to embrace digital transformation and broader societal impact, ensuring continued leadership in the biopharmaceutical sector.

UCB's mission is centered on transforming the lives of people living with severe diseases, particularly in neurology and immunology. The company's purpose statement emphasizes its dedication to creating value for patients and society through scientific innovation and a deep understanding of patient needs. This patient-centric approach is a cornerstone of the UCB company mission and its overall strategy. The UCB core values are integral to its operations, fostering a culture that drives its strategic goals. These values include acting with integrity, focusing on patients, collaborating effectively, and driving innovation. The UCB company culture is shaped by these principles, encouraging employees to contribute to the company's mission to improve patient lives. UCB's vision for the future of healthcare involves developing innovative treatments that address unmet medical needs and improve patient outcomes. The company's commitment to innovation in medicine is evident in its robust research and development pipeline. UCB's core values in leadership are demonstrated through a commitment to ethical conduct and a focus on long-term value creation. The company's corporate social responsibility initiatives are also guided by its core values and its commitment to making a positive impact. Understanding the Mission, Vision & Core Values of UCB provides insight into the company's strategic direction and its dedication to its stakeholders. For instance, UCB's investment in R&D reached approximately CHF 1.1 billion in 2023, underscoring its commitment to innovation. The company's focus on neurology and immunology targets diseases with significant unmet needs, reflecting its mission to address critical health challenges.